In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models. - Debnath T; Jin WJ; Patel RB; Carlson PM; Rahman MM; Berg TJ; Kerr CP; Schwartz RW; Wang Y; Hyun M; Ong IM; Weichert JP; et al. (Cancer immunology research, 2026)